GLP-1 DrugsApril 19, 2024
What Happens When You Quit Ozempic or Wegovy?
Many researchers think that Wegovy and Ozempic should be taken for life, but myriad factors can force people off the drugs
Stories by McKenzie Prillaman
McKenzie Prillaman is a science journalist based in Washington, DC. She earned her master's degree from the UC Santa Cruz Science Communication Program and was a news intern at Nature.
LanguageNovember 7, 2023
‘ChatGPT Detector’ Catches AI-Generated Papers with Unprecedented Accuracy
A new tool based on machine learning uses features of writing style to distinguish between human and AI authors
PharmaceuticalsJanuary 10, 2023
‘Breakthrough’ Obesity Drugs Are Effective but Raise Questions
Drugs that reduce excess weight linked to chronic health problems have shown striking results in trials and in practice
PharmaceuticalsDecember 1, 2022
Heralded Alzheimer’s Drug Works, but Safety Concerns Loom
Eisai and Biogen share clinical trial data confirming that lecanemab slows mental decline amid reports of potentially related deaths
NeurologySeptember 30, 2022
Alzheimer’s Drug Slows Mental Decline in Trial—But Is It a Breakthrough?
Researchers are cautiously optimistic following companies’ announcement of positive results for lecanemab
ArchaeologySeptember 13, 2022
Prehistoric Child’s Amputation Is Oldest Surgery of Its Kind
A skeleton missing its lower left leg and dated to 31,000 years ago provides the earliest known evidence for surgical limb removal